The Narnatumab Biosimilar Anti-MST1R Antibody is a crucial tool for researchers studying the immune system and its role in cancer and autoimmune disorders. This antibody, designed for use in Western blot applications, specifically targets the MST1R protein, a cell surface receptor with key implications in immune regulation. By binding to the MST1R protein, this antibody allows for the detection and analysis of MST1R in various cell types, providing valuable insights into immune response modulation.MST1R, also known as the macrophage-stimulating 1 receptor, is involved in a variety of cellular processes, including cell proliferation, migration, and survival. Dysregulation of MST1R signaling has been linked to cancer progression and metastasis, making it an important target for cancer research.
Additionally, MST1R has been implicated in autoimmune diseases and chronic inflammatory conditions, highlighting its significance in immune system functioning.By utilizing the Narnatumab Biosimilar Anti-MST1R Antibody, researchers can further our understanding of MST1R biology and its role in disease pathology. This antibody provides a valuable tool for investigating potential therapeutic interventions that target MST1R signaling pathways, offering new opportunities for the development of novel treatment strategies in cancer and autoimmune disorders.
Product Name:
Narnatumab (Anti-MST1R) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0103
Target:
MST1R
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
IMC RON-8, IMC-RON8, RON8
Description:
Anti-MST1R(narnatumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
